arch uk biocides limited
arch uk biocides limited Company Information
Company Number
04987690
Next Accounts
Sep 2025
Industry
Manufacture of soap and detergents
Shareholders
arch chemicals uk holdings ltd
hickson nederland bv
Group Structure
View All
Contact
Registered Address
hexagon tower crumpsall vale, blackley, manchester, M9 8GQ
Website
http://lonza.comarch uk biocides limited Estimated Valuation
Pomanda estimates the enterprise value of ARCH UK BIOCIDES LIMITED at £64.4m based on a Turnover of £40.8m and 1.58x industry multiple (adjusted for size and gross margin).
arch uk biocides limited Estimated Valuation
Pomanda estimates the enterprise value of ARCH UK BIOCIDES LIMITED at £68.3m based on an EBITDA of £6.9m and a 9.88x industry multiple (adjusted for size and gross margin).
arch uk biocides limited Estimated Valuation
Pomanda estimates the enterprise value of ARCH UK BIOCIDES LIMITED at £125.7m based on Net Assets of £57m and 2.21x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Arch Uk Biocides Limited Overview
Arch Uk Biocides Limited is a live company located in manchester, M9 8GQ with a Companies House number of 04987690. It operates in the manufacture of soap and detergents sector, SIC Code 20411. Founded in December 2003, it's largest shareholder is arch chemicals uk holdings ltd with a 98.2% stake. Arch Uk Biocides Limited is a mature, large sized company, Pomanda has estimated its turnover at £40.8m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Arch Uk Biocides Limited Health Check
Pomanda's financial health check has awarded Arch Uk Biocides Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 5 areas for improvement. Company Health Check FAQs
7 Strong
0 Regular
5 Weak
Size
annual sales of £40.8m, make it larger than the average company (£30.6m)
£40.8m - Arch Uk Biocides Limited
£30.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (5.3%)
-12% - Arch Uk Biocides Limited
5.3% - Industry AVG
Production
with a gross margin of 39.7%, this company has a lower cost of product (30.7%)
39.7% - Arch Uk Biocides Limited
30.7% - Industry AVG
Profitability
an operating margin of 16.3% make it more profitable than the average company (5.3%)
16.3% - Arch Uk Biocides Limited
5.3% - Industry AVG
Employees
with 75 employees, this is below the industry average (99)
75 - Arch Uk Biocides Limited
99 - Industry AVG
Pay Structure
on an average salary of £75k, the company has a higher pay structure (£44.1k)
£75k - Arch Uk Biocides Limited
£44.1k - Industry AVG
Efficiency
resulting in sales per employee of £544.2k, this is more efficient (£219.5k)
£544.2k - Arch Uk Biocides Limited
£219.5k - Industry AVG
Debtor Days
it gets paid by customers after 47 days, this is earlier than average (65 days)
47 days - Arch Uk Biocides Limited
65 days - Industry AVG
Creditor Days
its suppliers are paid after 8 days, this is quicker than average (52 days)
8 days - Arch Uk Biocides Limited
52 days - Industry AVG
Stock Days
it holds stock equivalent to 112 days, this is more than average (59 days)
112 days - Arch Uk Biocides Limited
59 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 10 weeks, this is more cash available to meet short term requirements (5 weeks)
10 weeks - Arch Uk Biocides Limited
5 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.4%, this is a lower level of debt than the average (49.3%)
19.4% - Arch Uk Biocides Limited
49.3% - Industry AVG
ARCH UK BIOCIDES LIMITED financials
Arch Uk Biocides Limited's latest turnover from December 2023 is £40.8 million and the company has net assets of £57 million. According to their latest financial statements, Arch Uk Biocides Limited has 75 employees and maintains cash reserves of £2.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 40,812,000 | 45,918,000 | 45,230,000 | 60,058,000 | 69,750,000 | 58,283,000 | 64,503,000 | 59,772,000 | 57,738,000 | 59,635,000 | 64,911,000 | 63,462,000 | 67,260,000 | 70,868,000 | 65,334,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 24,592,000 | 27,034,000 | 32,980,000 | 44,281,000 | 46,273,000 | 40,769,000 | 50,764,000 | 46,895,000 | 48,373,000 | 51,325,000 | 52,006,000 | 50,145,000 | 55,074,000 | 54,213,000 | 49,816,000 |
| Gross Profit | 16,220,000 | 18,884,000 | 12,250,000 | 15,777,000 | 23,477,000 | 17,514,000 | 13,739,000 | 12,877,000 | 9,365,000 | 8,310,000 | 12,905,000 | 13,317,000 | 12,186,000 | 16,655,000 | 15,518,000 |
| Admin Expenses | 9,555,000 | 17,302,000 | 13,035,000 | 250,000 | 13,609,000 | 10,402,000 | 10,544,000 | 10,150,000 | 7,886,000 | 11,433,000 | 12,158,000 | 10,379,000 | 13,741,000 | 38,631,000 | 8,586,000 |
| Operating Profit | 6,665,000 | 1,582,000 | -785,000 | 15,527,000 | 9,868,000 | 7,112,000 | 3,195,000 | 2,727,000 | 1,479,000 | -3,123,000 | 747,000 | 2,938,000 | -1,555,000 | -21,976,000 | 6,932,000 |
| Interest Payable | 604,000 | 9,000 | 12,000 | 0 | 0 | 0 | 16,000 | 58,000 | 243,000 | 595,000 | 803,000 | 1,758,000 | 2,042,000 | 136,000 | 844,000 |
| Interest Receivable | 227,000 | 1,278,000 | 151,000 | 431,000 | 88,000 | 24,000 | 60,000 | 33,000 | 82,000 | 1,000 | 1,039,000 | 1,180,000 | 299,000 | 91,000 | |
| Pre-Tax Profit | 6,288,000 | 2,851,000 | -1,023,000 | 15,958,000 | 9,539,000 | 7,553,000 | 2,643,000 | 4,777,000 | 1,490,000 | -3,470,000 | 138,000 | 2,219,000 | -2,417,000 | -14,014,000 | 9,826,000 |
| Tax | -1,541,000 | -1,487,000 | -316,000 | -3,169,000 | -2,506,000 | -1,410,000 | -498,000 | -892,000 | 1,064,000 | -836,000 | -340,000 | -702,000 | -404,000 | -1,291,000 | -953,000 |
| Profit After Tax | 4,747,000 | 1,364,000 | -1,339,000 | 12,789,000 | 7,033,000 | 6,143,000 | 2,145,000 | 3,885,000 | 2,554,000 | -4,306,000 | -202,000 | 1,517,000 | -2,821,000 | -15,305,000 | 8,873,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 4,747,000 | 1,364,000 | -1,339,000 | 12,789,000 | 7,033,000 | 6,143,000 | 2,145,000 | 3,885,000 | 2,554,000 | -4,306,000 | -202,000 | 1,517,000 | -2,821,000 | -15,305,000 | 8,873,000 |
| Employee Costs | 5,625,000 | 5,663,000 | 6,398,000 | 5,396,000 | 4,765,000 | 5,129,000 | 5,044,000 | 3,658,000 | 2,972,000 | 3,534,000 | 4,826,000 | 4,038,000 | 3,376,000 | 3,500,000 | 3,207,000 |
| Number Of Employees | 75 | 80 | 88 | 82 | 71 | 76 | 80 | 76 | 86 | 100 | 93 | 83 | 81 | 81 | 77 |
| EBITDA* | 6,914,000 | 1,839,000 | -512,000 | 15,707,000 | 11,732,000 | 7,530,000 | 10,653,000 | 10,102,000 | 8,817,000 | 4,359,000 | 4,236,000 | 6,450,000 | 2,221,000 | -18,217,000 | 10,668,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,230,000 | 1,284,000 | 1,410,000 | 1,093,000 | 8,295,000 | 3,006,000 | 3,008,000 | 2,450,000 | 2,239,000 | 2,740,000 | 2,577,000 | 2,187,000 | 1,661,000 | 1,981,000 | 1,657,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,142,000 | 14,262,000 | 21,382,000 | 28,502,000 | 35,622,000 | 38,788,000 | 41,954,000 | 45,120,000 |
| Investments & Other | 3,945,000 | 5,057,000 | 9,663,000 | 5,484,000 | 0 | 5,032,000 | 1,951,000 | 18,000 | 2,180,000 | 18,000 | 1,427,000 | 18,000 | 287,000 | 18,000 | 33,473,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 5,175,000 | 6,341,000 | 11,073,000 | 6,577,000 | 8,295,000 | 8,038,000 | 4,959,000 | 9,610,000 | 18,681,000 | 24,140,000 | 32,506,000 | 37,827,000 | 40,736,000 | 43,953,000 | 80,250,000 |
| Stock & work in progress | 7,563,000 | 7,792,000 | 7,198,000 | 9,248,000 | 13,327,000 | 8,500,000 | 9,978,000 | 13,953,000 | 10,559,000 | 13,483,000 | 13,962,000 | 14,115,000 | 9,269,000 | 10,459,000 | 7,559,000 |
| Trade Debtors | 5,327,000 | 6,156,000 | 6,254,000 | 7,045,000 | 7,933,000 | 7,750,000 | 9,450,000 | 9,052,000 | 11,129,000 | 6,297,000 | 5,981,000 | 6,164,000 | 6,143,000 | 6,650,000 | 6,608,000 |
| Group Debtors | 48,544,000 | 43,320,000 | 36,722,000 | 38,655,000 | 0 | 3,101,000 | 3,147,000 | 2,049,000 | 0 | 4,158,000 | 4,984,000 | 9,791,000 | 3,963,000 | 8,444,000 | 27,656,000 |
| Misc Debtors | 1,486,000 | 1,261,000 | 1,639,000 | 965,000 | 0 | 14,367,000 | 1,008,000 | 2,210,000 | 0 | 2,772,000 | 3,203,000 | 3,006,000 | 2,959,000 | 3,069,000 | 3,019,000 |
| Cash | 2,658,000 | 1,002,000 | 1,913,000 | 6,978,000 | 9,225,000 | 6,552,000 | 14,111,000 | 4,893,000 | 0 | 0 | 1,650,000 | 5,916,000 | 7,183,000 | 7,710,000 | 6,505,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 65,578,000 | 59,531,000 | 53,726,000 | 62,891,000 | 57,297,000 | 40,270,000 | 37,694,000 | 32,157,000 | 21,688,000 | 26,710,000 | 29,780,000 | 38,992,000 | 29,517,000 | 36,332,000 | 51,347,000 |
| total assets | 70,753,000 | 65,872,000 | 64,799,000 | 69,468,000 | 65,592,000 | 48,308,000 | 42,653,000 | 41,767,000 | 40,369,000 | 50,850,000 | 62,286,000 | 76,819,000 | 70,253,000 | 80,285,000 | 131,597,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,340,000 | 2,935,000 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 601,000 | 862,000 | 7,592,000 | 669,000 | 1,607,000 | 1,648,000 | 1,869,000 | 2,272,000 | 2,323,000 | 3,003,000 | 2,408,000 | 1,846,000 | 688,000 | 1,211,000 | 844,000 |
| Group/Directors Accounts | 8,561,000 | 6,518,000 | 0 | 8,023,000 | 0 | 6,620,000 | 9,817,000 | 11,629,000 | 9,177,000 | 22,318,000 | 31,863,000 | 13,230,000 | 4,643,000 | 5,003,000 | 14,755,000 |
| other short term finances | 0 | 0 | 0 | 0 | 11,646,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 124,000 | 123,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 3,659,000 | 3,905,000 | 0 | 6,595,000 | 0 | 4,251,000 | 2,597,000 | 2,331,000 | 1,437,000 | 2,101,000 | 1,475,000 | 7,150,000 | 9,327,000 | 6,869,000 | 5,216,000 |
| total current liabilities | 12,945,000 | 11,408,000 | 7,592,000 | 15,287,000 | 18,837,000 | 12,519,000 | 14,283,000 | 16,232,000 | 17,277,000 | 30,357,000 | 35,746,000 | 22,226,000 | 14,658,000 | 13,083,000 | 20,815,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28,647,000 | 30,217,000 | 38,250,000 | 0 |
| hp & lease commitments | 22,000 | 134,000 | 250,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 768,000 | 892,000 | 1,880,000 | 570,000 | 0 | 304,000 | 304,000 | 305,000 | 304,000 | 304,000 | 304,000 | 0 | 0 | 0 | 0 |
| total long term liabilities | 790,000 | 1,026,000 | 2,130,000 | 570,000 | 3,624,000 | 304,000 | 304,000 | 1,713,000 | 304,000 | 489,000 | 304,000 | 28,966,000 | 30,217,000 | 39,885,000 | 1,858,000 |
| total liabilities | 13,735,000 | 12,434,000 | 9,722,000 | 15,857,000 | 22,461,000 | 12,823,000 | 14,587,000 | 17,945,000 | 17,581,000 | 30,846,000 | 36,050,000 | 51,192,000 | 44,875,000 | 52,968,000 | 22,673,000 |
| net assets | 57,018,000 | 53,438,000 | 55,077,000 | 53,611,000 | 43,131,000 | 35,485,000 | 28,066,000 | 23,822,000 | 22,788,000 | 20,004,000 | 26,236,000 | 25,627,000 | 25,378,000 | 27,317,000 | 108,924,000 |
| total shareholders funds | 57,018,000 | 53,438,000 | 55,077,000 | 53,611,000 | 43,131,000 | 35,485,000 | 28,066,000 | 23,822,000 | 22,788,000 | 20,004,000 | 26,236,000 | 25,627,000 | 25,378,000 | 27,317,000 | 108,924,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 6,665,000 | 1,582,000 | -785,000 | 15,527,000 | 9,868,000 | 7,112,000 | 3,195,000 | 2,727,000 | 1,479,000 | -3,123,000 | 747,000 | 2,938,000 | -1,555,000 | -21,976,000 | 6,932,000 |
| Depreciation | 249,000 | 257,000 | 273,000 | 180,000 | 1,864,000 | 418,000 | 316,000 | 255,000 | 218,000 | 363,000 | 323,000 | 346,000 | 610,000 | 593,000 | 570,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 7,142,000 | 7,120,000 | 7,120,000 | 7,119,000 | 3,166,000 | 3,166,000 | 3,166,000 | 3,166,000 | 3,166,000 | |
| Tax | -1,541,000 | -1,487,000 | -316,000 | -3,169,000 | -2,506,000 | -1,410,000 | -498,000 | -892,000 | 1,064,000 | -836,000 | -340,000 | -702,000 | -404,000 | -1,291,000 | -953,000 |
| Stock | -229,000 | 594,000 | -2,050,000 | -4,079,000 | 4,827,000 | -1,478,000 | -3,975,000 | 3,394,000 | -2,924,000 | -479,000 | -153,000 | 4,846,000 | -1,190,000 | 2,900,000 | 7,559,000 |
| Debtors | 4,620,000 | 6,122,000 | -2,050,000 | 38,732,000 | -17,285,000 | 11,613,000 | 294,000 | 2,182,000 | -2,098,000 | -941,000 | -4,793,000 | 5,896,000 | -5,098,000 | -19,120,000 | 37,283,000 |
| Creditors | -261,000 | -6,730,000 | 6,923,000 | -938,000 | -41,000 | -221,000 | -403,000 | -51,000 | -680,000 | 595,000 | 562,000 | 1,158,000 | -523,000 | 367,000 | 844,000 |
| Accruals and Deferred Income | -246,000 | 3,905,000 | -6,595,000 | 6,595,000 | -4,251,000 | 1,654,000 | 266,000 | 894,000 | -664,000 | 626,000 | -5,675,000 | -2,177,000 | 2,458,000 | 1,653,000 | 5,216,000 |
| Deferred Taxes & Provisions | -124,000 | -988,000 | 1,310,000 | 570,000 | -304,000 | 0 | -1,000 | 1,000 | 0 | 0 | 304,000 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 351,000 | -10,177,000 | 4,910,000 | -15,888,000 | -2,582,000 | 13,698,000 | 4,478,000 | 13,559,000 | 6,164,000 | 4,033,000 | -6,013,000 | 10,040,000 | -1,268,000 | -29,067,000 | |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -1,112,000 | -4,606,000 | 4,179,000 | 5,484,000 | -5,032,000 | 3,081,000 | 1,933,000 | -2,162,000 | 2,162,000 | -1,409,000 | 1,409,000 | -269,000 | 269,000 | -33,455,000 | 33,473,000 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 2,043,000 | 6,518,000 | -8,023,000 | 8,023,000 | -6,620,000 | -3,197,000 | -1,812,000 | 2,452,000 | -13,141,000 | -9,545,000 | 18,633,000 | 8,587,000 | -360,000 | -9,752,000 | 14,755,000 |
| Other Short Term Loans | 0 | 0 | 0 | -11,646,000 | 11,646,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28,647,000 | -1,570,000 | -8,033,000 | 38,250,000 | 0 |
| Hire Purchase and Lease Commitments | -111,000 | 7,000 | 250,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | -377,000 | 1,269,000 | 139,000 | 431,000 | 88,000 | 8,000 | 2,000 | -210,000 | -513,000 | -802,000 | -719,000 | -862,000 | 163,000 | -753,000 | |
| cash flow from financing | 388,000 | 4,791,000 | -4,829,000 | -5,501,000 | -1,833,000 | 295,000 | -397,000 | -13,121,000 | -11,984,000 | -10,005,000 | 5,030,000 | -8,373,000 | -37,641,000 | 114,053,000 | |
| cash and cash equivalents | |||||||||||||||
| cash | 1,656,000 | -911,000 | -5,065,000 | -2,247,000 | 2,673,000 | -7,559,000 | 9,218,000 | 4,893,000 | 0 | -1,650,000 | -4,266,000 | -1,267,000 | -527,000 | 1,205,000 | 6,505,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,340,000 | 1,405,000 | 2,935,000 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 1,656,000 | -911,000 | -5,065,000 | -2,247,000 | 2,673,000 | -7,559,000 | 9,218,000 | 9,233,000 | -1,405,000 | -4,585,000 | -4,266,000 | -1,267,000 | -527,000 | 1,205,000 | 6,505,000 |
arch uk biocides limited Credit Report and Business Information
Arch Uk Biocides Limited Competitor Analysis
Perform a competitor analysis for arch uk biocides limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in M 9 area or any other competitors across 12 key performance metrics.
arch uk biocides limited Ownership
ARCH UK BIOCIDES LIMITED group structure
Arch Uk Biocides Limited has 1 subsidiary company.
Ultimate parent company
ARCH CHEMICALS HOLDINGS INC
#0038786
2 parents
ARCH UK BIOCIDES LIMITED
04987690
1 subsidiary
arch uk biocides limited directors
Arch Uk Biocides Limited currently has 3 directors. The longest serving directors include Mr Nicholas Carter (Nov 2016) and Mr Jordan Petkov (Feb 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nicholas Carter | United Kingdom | 43 years | Nov 2016 | - | Director |
| Mr Jordan Petkov | United Kingdom | 58 years | Feb 2018 | - | Director |
| Jacov Wirtz | United Kingdom | 47 years | Jun 2024 | - | Director |
P&L
December 2023turnover
40.8m
-11%
operating profit
6.7m
+321%
gross margin
39.8%
-3.36%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
57m
+0.07%
total assets
70.8m
+0.07%
cash
2.7m
+1.65%
net assets
Total assets minus all liabilities
arch uk biocides limited company details
company number
04987690
Type
Private limited with Share Capital
industry
20411 - Manufacture of soap and detergents
incorporation date
December 2003
age
21
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
trushelfco (no.3020) limited (February 2004)
accountant
-
auditor
RODL & PARTNER LIMITED
address
hexagon tower crumpsall vale, blackley, manchester, M9 8GQ
Bank
-
Legal Advisor
-
arch uk biocides limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to arch uk biocides limited.
arch uk biocides limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ARCH UK BIOCIDES LIMITED. This can take several minutes, an email will notify you when this has completed.
arch uk biocides limited Companies House Filings - See Documents
| date | description | view/download |
|---|
